Alpa Laboratories Ltd – Company Report
1. Company Overview
Alpa Laboratories Ltd., founded in 1967 and headquartered near Indore, Madhya Pradesh, is a leading Indian manufacturer of pharmaceutical finished dosage forms. Operating a WHO-GMP and ISO 9001:2000 certified facility spread over 1.2 acres in Pigdamber, the company has more than five decades of pharmaceutical manufacturing expertise. Alpa Labs is known for its consistent quality, regulatory compliance, and partnerships with both Indian and international pharmaceutical clients.
With over 200 professionals on board, the company serves both the human and veterinary medicine markets, exporting a wide range of products globally. Its emphasis on stringent quality assurance and continuous improvement has helped maintain long-term credibility with healthcare partners.
- Incorporated: 1967
- Headquarters: Indore, Madhya Pradesh, India
- Employees: 201–500
- Certifications: WHO-GMP, ISO 9001:2000
- Facility: 1.2 acres, specialized FDF manufacturing near Indore
- Listed On: BSE and NSE
2. Products and Services
Alpa Laboratories Ltd. manufactures a wide portfolio of pharmaceutical products across various finished dosage forms:
Key Product Offerings
Tablets and Capsules:
Includes antibiotics, analgesics, anti-infectives, antipyretics, and multivitamins such as Cephalexin, Ampicillin & Cloxacillin, Azithromycin, Lansoprazole, Paracetamol variants.Injectables:
Specializes in dry and liquid injections for both human and veterinary use.Ointments, Creams, and Gels:
Dermatological and anti-inflammatory formulations like Betamethasone Valerate, Hydrocortisone Acetate, Nystatin Ointment, Diclofenac Diethylamine Gel.Ophthalmic and Ear Drops:
Solutions for infections and inflammation in the eyes and ears.Syrups and Suspensions:
Includes cough syrups, anti-allergics, antibiotics, and pediatric formulations.Veterinary Formulations:
A broad range including injectables and oral medications.
Custom Manufacturing and Contract Services
- Supplies under its own brand and also for leading Indian and multinational pharmaceutical companies.
- Offers ethical (prescription), generic, and OTC drug variants.
- Manufacturing lines meet global regulatory standards and undergo regular audits.
3. Recent News & Financial Performance
Recent Developments
- Alpa Laboratories returned to revenue growth in FY2025 after a temporary contraction in FY2024.
- Continued investments in product diversification and capacity expansion, especially in high-margin segments.
- Leadership remains with Chairman & Executive Director Mahendra Singh Chawla and Managing Director Paresh Chawla.
- February 21, 2025: State health minister Dinesh Gundu Rao wrote to the union health minister JP Nadda on Thursday to highlight the repeated instances of sale of such contaminated drugs in the state.The letter includes Diclofenac Sodium solution, a painkiller, manufactured by Pharma Impex Laboratories, West Bengal, and Metronidazole 100 ml injection, an antibiotic, manufactured by Alpa laboratories, Indore, and IHL Lifesciences, Madhya Pradesh.
4. Financial Performance (FY2025)
| Metric | Value |
|---|---|
| Net Sales | ₹112 crore (FY2025), up from ₹109 crore in FY2024 |
| Net Profit | ₹20 crore (FY2025) |
| Basic EPS | ₹9.27 |
| Operating Profit Margin (OPM) | ~4% |
| Return on Equity (ROE) | 12.1% |
| Debt | Almost debt-free |
| Dividend | No dividend declared; profits retained for reinvestment |